Abstract 1059: Paricalcitol, hydroxychloroquine and gemcitabine promote antitumor effects and modulate immune profile in pancreatic ductal adenocarcinoma

Abstract 1059: Paricalcitol, hydroxychloroquine and gemcitabine promote antitumor effects and modulate immune profile in pancreatic ductal adenocarcinoma

Background Pancreatic ductal adenocarcinoma (PDAC) has low (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2022-06, Vol.82 (12_Supplement), p.1059-1059
Hauptverfasser: Ganji, Purnachandra Nagaraju, Thomas, Beena Elizabeth, Phillips, Maggie, Herting, Cameron, Ruggieri, Amanda, Keilson, Jessica Millian, Turgeon, Michael Kim, Saraswatula, Sisira, Pilcher, William, Lesinski, Gregory B., Bhasin, Manoj, El-Rayes, Bassel F.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Pancreatic ductal adenocarcinoma (PDAC) has low (
ISSN:1538-7445
1538-7445
DOI:10.1158/1538-7445.AM2022-1059